Over the current book year the total revenue from the company in New York City will be 73.51 billion USD (consensus estimates). This is rather significant more than 2021's revenue of 41.91 billion USD.
The analysts expect for 2021 a net profit of 21.19 billion USD. For this year the consensus of the result per share is a profit of 3.73 USD. The price/earnings-ratio therefore equals 11.01.
Pfizer 's market capitalization is around 227.17 billion USD. 23
At 21.24 the stock trades 0 percent lower at 41.05 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.